Abstract
IN a previous publication from these laboratories it was demonstrated that the intravenous injection of a viable cell suspension of tumour, the dbrB adenocarcinoma, indigenous to the strain of origin, the DBA/1 mouse, elicited complete resistance to the growth of a subsequent subcutaneous implant of this same tumour, but that many of the animals died of pulmonary tumours resulting from the primary intravenous injection of viable tumour cells1. Further, when this same strain of animal was pretreated intravenously with similar tumour cells attenuated or killed with alcohol, in an effort to eliminate the development of lung tumours, only partial resistance to challenge growth was effected2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prince, J. E., Fardon, J. C., Nutini, L. G., and Sperti, G. S., Cancer Res., 17, 312 (1957).
Prince, J. E., Morgan, C. M., Fardon, J. C., Nutini, L. G., and Duarte, A. G., Cancer Res., 18, 760 (1958).
Loofbourow, J. R., Cook, E. S., and Stimson, Sr. M. M., Nature, 142, 573 (1938).
Loofbourow, J. R., Dwyer, Sr. C. M., and Cronin, Sr. A. G., Biochem. J., 35, 603 (1941).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
COSBY, M., NUTINI, L., COOK, E. et al. Induction of Resistance to an Isologous Tumour by Ultra-violet Attenuated Tumour Cells. Nature 195, 1111–1112 (1962). https://doi.org/10.1038/1951111b0
Issue Date:
DOI: https://doi.org/10.1038/1951111b0
This article is cited by
-
Immunological Properties of Tumours
Nature (1963)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.